ELEVANCE HEALTH INC (ELV) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:ELV - US0367521038 - Common Stock
338.26 USD
-0.26 (-0.08%)
338.26 USD
0 (0%)
ELV gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 101 industry peers in the Health Care Providers & Services industry. While ELV is still in line with the averages on profitability rating, there are concerns on its financial health. ELV has a correct valuation and a medium growth rate. Finally ELV also has an excellent dividend rating.
1. Profitability
1.1 Basic Checks
ELV had positive earnings in the past year.
ELV had a positive operating cash flow in the past year.
In the past 5 years ELV has always been profitable.
ELV had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
ELV has a better Return On Assets (4.51%) than 74.26% of its industry peers.
Looking at the Return On Equity, with a value of 12.59%, ELV is in the better half of the industry, outperforming 78.22% of the companies in the same industry.
ELV has a Return On Invested Capital (5.60%) which is in line with its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ELV is below the industry average of 9.26%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.51% | ||
| ROE | 12.59% | ||
| ROIC | 5.6% |
ROA(3y)5.45%
ROA(5y)5.58%
ROE(3y)15.32%
ROE(5y)15.33%
ROIC(3y)6.9%
ROIC(5y)7.19%
1.3 Margins
The Profit Margin of ELV (2.84%) is better than 65.35% of its industry peers.
In the last couple of years the Profit Margin of ELV has declined.
ELV has a Operating Margin (4.35%) which is comparable to the rest of the industry.
In the last couple of years the Operating Margin of ELV has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.35% | ||
| PM (TTM) | 2.84% | ||
| GM | N/A |
OM growth 3Y-7.78%
OM growth 5Y-4.45%
PM growth 3Y-8.42%
PM growth 5Y-6.01%
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ELV is destroying value.
Compared to 1 year ago, ELV has less shares outstanding
ELV has less shares outstanding than it did 5 years ago.
ELV has a worse debt/assets ratio than last year.
2.2 Solvency
ELV has a debt to FCF ratio of 8.63. This is a slightly negative value and a sign of low solvency as ELV would need 8.63 years to pay back of all of its debts.
ELV has a Debt to FCF ratio (8.63) which is comparable to the rest of the industry.
A Debt/Equity ratio of 0.71 indicates that ELV is somewhat dependend on debt financing.
ELV has a Debt to Equity ratio (0.71) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.71 | ||
| Debt/FCF | 8.63 | ||
| Altman-Z | N/A |
ROIC/WACC0.67
WACC8.34%
2.3 Liquidity
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | N/A | ||
| Quick Ratio | N/A |
3. Growth
3.1 Past
The earnings per share for ELV have decreased strongly by -11.71% in the last year.
Measured over the past years, ELV shows a quite strong growth in Earnings Per Share. The EPS has been growing by 11.17% on average per year.
Looking at the last year, ELV shows a quite strong growth in Revenue. The Revenue has grown by 11.96% in the last year.
ELV shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.14% yearly.
EPS 1Y (TTM)-11.71%
EPS 3Y8.28%
EPS 5Y11.17%
EPS Q2Q%-27.96%
Revenue 1Y (TTM)11.96%
Revenue growth 3Y8.44%
Revenue growth 5Y11.14%
Sales Q2Q%12%
3.2 Future
ELV is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.78% yearly.
Based on estimates for the next years, ELV will show a small growth in Revenue. The Revenue will grow by 4.62% on average per year.
EPS Next Y-8.18%
EPS Next 2Y-8.53%
EPS Next 3Y-1.23%
EPS Next 5Y7.78%
Revenue Next Year13.06%
Revenue Next 2Y8.03%
Revenue Next 3Y7.01%
Revenue Next 5Y4.62%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
ELV is valuated reasonably with a Price/Earnings ratio of 11.03.
90.10% of the companies in the same industry are more expensive than ELV, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of ELV to the average of the S&P500 Index (26.31), we can say ELV is valued rather cheaply.
The Price/Forward Earnings ratio is 12.26, which indicates a correct valuation of ELV.
85.15% of the companies in the same industry are more expensive than ELV, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 36.59. ELV is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.03 | ||
| Fwd PE | 12.26 |
4.2 Price Multiples
ELV's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. ELV is cheaper than 74.26% of the companies in the same industry.
ELV's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. ELV is cheaper than 64.36% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 20.47 | ||
| EV/EBITDA | 9.93 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)0.99
EPS Next 2Y-8.53%
EPS Next 3Y-1.23%
5. Dividend
5.1 Amount
ELV has a Yearly Dividend Yield of 2.02%.
Compared to an average industry Dividend Yield of 2.60, ELV pays a better dividend. On top of this ELV pays more dividend than 91.09% of the companies listed in the same industry.
ELV's Dividend Yield is comparable with the S&P500 average which is at 2.40.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.02% |
5.2 History
The dividend of ELV is nicely growing with an annual growth rate of 15.34%!
ELV has paid a dividend for at least 10 years, which is a reliable track record.
ELV has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)15.34%
Div Incr Years13
Div Non Decr Years13
5.3 Sustainability
27.56% of the earnings are spent on dividend by ELV. This is a low number and sustainable payout ratio.
The dividend of ELV is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP27.56%
EPS Next 2Y-8.53%
EPS Next 3Y-1.23%
338.26
-0.26 (-0.08%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners93.05%
Inst Owner ChangeN/A
Ins Owners0.14%
Ins Owner Change2.02%
Market Cap75.17B
Revenue(TTM)194.82B
Net Income(TTM)5.53B
Analysts75.17
Price Target391.07 (15.61%)
Short Float %1.55%
Short Ratio1.89
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.02% |
Yearly Dividend6.55
Dividend Growth(5Y)15.34%
DP27.56%
Div Incr Years13
Div Non Decr Years13
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)9.38%
Min EPS beat(2)-2.26%
Max EPS beat(2)21.02%
EPS beat(4)3
Avg EPS beat(4)5.76%
Min EPS beat(4)-2.26%
Max EPS beat(4)21.02%
EPS beat(8)5
Avg EPS beat(8)0.95%
EPS beat(12)8
Avg EPS beat(12)1.31%
EPS beat(16)11
Avg EPS beat(16)1.68%
Revenue beat(2)2
Avg Revenue beat(2)0.95%
Min Revenue beat(2)0.45%
Max Revenue beat(2)1.45%
Revenue beat(4)3
Avg Revenue beat(4)1.37%
Min Revenue beat(4)-0.71%
Max Revenue beat(4)4.3%
Revenue beat(8)4
Avg Revenue beat(8)0.64%
Revenue beat(12)6
Avg Revenue beat(12)0.78%
Revenue beat(16)9
Avg Revenue beat(16)0.69%
PT rev (1m)4.69%
PT rev (3m)5.23%
EPS NQ rev (1m)-22.55%
EPS NQ rev (3m)-22.67%
EPS NY rev (1m)0.26%
EPS NY rev (3m)0.26%
Revenue NQ rev (1m)0.24%
Revenue NQ rev (3m)0.58%
Revenue NY rev (1m)0.52%
Revenue NY rev (3m)0.7%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.03 | ||
| Fwd PE | 12.26 | ||
| P/S | 0.39 | ||
| P/FCF | 20.47 | ||
| P/OCF | 15.65 | ||
| P/B | 1.73 | ||
| P/tB | 18.24 | ||
| EV/EBITDA | 9.93 |
EPS(TTM)30.68
EY9.07%
EPS(NY)27.58
Fwd EY8.15%
FCF(TTM)16.52
FCFY4.89%
OCF(TTM)21.61
OCFY6.39%
SpS865.17
BVpS195.19
TBVpS18.54
PEG (NY)N/A
PEG (5Y)0.99
Graham Number367.07
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.51% | ||
| ROE | 12.59% | ||
| ROCE | 7.32% | ||
| ROIC | 5.6% | ||
| ROICexc | 6.06% | ||
| ROICexgc | 10.93% | ||
| OM | 4.35% | ||
| PM (TTM) | 2.84% | ||
| GM | N/A | ||
| FCFM | 1.91% |
ROA(3y)5.45%
ROA(5y)5.58%
ROE(3y)15.32%
ROE(5y)15.33%
ROIC(3y)6.9%
ROIC(5y)7.19%
ROICexc(3y)7.45%
ROICexc(5y)7.72%
ROICexgc(3y)13.9%
ROICexgc(5y)14.63%
ROCE(3y)9.03%
ROCE(5y)9.4%
ROICexgc growth 3Y-5.49%
ROICexgc growth 5Y-3.16%
ROICexc growth 3Y-5.02%
ROICexc growth 5Y-2.23%
OM growth 3Y-7.78%
OM growth 5Y-4.45%
PM growth 3Y-8.42%
PM growth 5Y-6.01%
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover1.59
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.71 | ||
| Debt/FCF | 8.63 | ||
| Debt/EBITDA | 3.13 | ||
| Cap/Depr | 74.45% | ||
| Cap/Sales | 0.59% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 48.59% | ||
| Profit Quality | 67.25% | ||
| Current Ratio | N/A | ||
| Quick Ratio | N/A | ||
| Altman-Z | N/A |
F-Score4
WACC8.34%
ROIC/WACC0.67
Cap/Depr(3y)77.74%
Cap/Depr(5y)81.03%
Cap/Sales(3y)0.73%
Cap/Sales(5y)0.76%
Profit Quality(3y)103.66%
Profit Quality(5y)128.32%
High Growth Momentum
Growth
EPS 1Y (TTM)-11.71%
EPS 3Y8.28%
EPS 5Y11.17%
EPS Q2Q%-27.96%
EPS Next Y-8.18%
EPS Next 2Y-8.53%
EPS Next 3Y-1.23%
EPS Next 5Y7.78%
Revenue 1Y (TTM)11.96%
Revenue growth 3Y8.44%
Revenue growth 5Y11.14%
Sales Q2Q%12%
Revenue Next Year13.06%
Revenue Next 2Y8.03%
Revenue Next 3Y7.01%
Revenue Next 5Y4.62%
EBIT growth 1Y-10.69%
EBIT growth 3Y0%
EBIT growth 5Y6.19%
EBIT Next Year-1.57%
EBIT Next 3Y2.35%
EBIT Next 5Y8.31%
FCF growth 1Y-54.88%
FCF growth 3Y-14.89%
FCF growth 5Y-2.08%
OCF growth 1Y-48.85%
OCF growth 3Y-11.78%
OCF growth 5Y-1.08%
ELEVANCE HEALTH INC / ELV FAQ
Can you provide the ChartMill fundamental rating for ELEVANCE HEALTH INC?
ChartMill assigns a fundamental rating of 4 / 10 to ELV.
What is the valuation status for ELV stock?
ChartMill assigns a valuation rating of 6 / 10 to ELEVANCE HEALTH INC (ELV). This can be considered as Fairly Valued.
What is the profitability of ELV stock?
ELEVANCE HEALTH INC (ELV) has a profitability rating of 4 / 10.
Can you provide the expected EPS growth for ELV stock?
The Earnings per Share (EPS) of ELEVANCE HEALTH INC (ELV) is expected to decline by -8.18% in the next year.
Is the dividend of ELEVANCE HEALTH INC sustainable?
The dividend rating of ELEVANCE HEALTH INC (ELV) is 7 / 10 and the dividend payout ratio is 27.56%.